Lisanti Capital Growth LLC acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 212,935 shares of the medical research company’s stock, valued at approximately $3,445,000. Lisanti Capital Growth LLC owned approximately 0.17% […]